GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Rafael Holdings Inc.
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Its share price reflects the value of these diverse assets and the company's history of restructuring following the failure of its biotech division.
Share prices of companies in the market segment - Investors holding
Rafael Holdings is a holding company that owns stakes in pharmaceutical companies and real estate. We've classified it as a "Holding Investor," and the chart below shows how the market values โโcompanies with mixed and diversified assets.
Broad Market Index - GURU.Markets
Rafael Holdings is a holding company that owns stakes in pharmaceutical companies and real estate. It is a component of the GURU.Markets index. The chart below represents the market. See how this holding's shares compare to the overall trend.
Change in the price of a company, segment, and market as a whole per day
RFL - Daily change in the company's share price Rafael Holdings Inc.
For Rafael Holdings, Inc., a holding company focused on real estate and pharmaceuticals, daily volatility reflects sensitivity to news from both sectors. This metric is an indicator of the effectiveness of diversified asset management.
Daily change in the price of a set of shares in a market segment - Investors holding
Rafael Holdings, Inc. is a holding company. This chart shows average daily volatility. Comparing it to RFL, with its investments in real estate and pharmaceuticals, helps assess how diversification impacts its stability.
Daily change in the price of a broad market stock, index - GURU.Markets
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Its stock price reflects the combined impact of these diverse businesses and contributes uniquely to the complex and multifaceted picture of overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Rafael Holdings Inc.
Rafael Holdings, Inc.'s year-over-year performance is a story of transformation. Following the failure of its lead oncology drug, its 12-month market cap reflects its new strategy of expanding its real estate portfolio and investing in other biotech companies, an attempt to find a new path to value creation.
Annual dynamics of market capitalization of the market segment - Investors holding
Rafael Holdings, Inc. is a holding company with assets in real estate and pharmaceuticals. Its complex structure and reliance on R&D success make it a unique and volatile asset. The chart below shows how the market views its diverse businesses and strategy.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Rafael is a holding company investing in real estate and biotechnology. Its stock price is the sum of several unrelated cycles. The company's chart reflects the specifics of its assets and management strategy rather than general trends, making it difficult to analyze.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Rafael Holdings Inc.
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Its monthly performance is the sum of its various holdings. News about clinical trials of its pharmaceutical investments or real estate deals are key drivers.
Monthly dynamics of market capitalization of the market segment - Investors holding
Rafael Holdings is a holding company investing in real estate and pharmaceutical developments. Its diversified structure requires investors to evaluate each area. The chart below shows the overall performance of the holding companies, which can serve as a benchmark for analyzing Rafael.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Rafael Holdings, Inc. is a holding company with assets in real estate and biotechnology. Its diversified nature can smooth out fluctuations. However, its significant biotech exposure introduces an element of unpredictability, and stock performance can fluctuate sharply based on news from its portfolio companies.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Rafael Holdings Inc.
The weekly performance of Rafael Holdings, a holding company with assets in real estate and biotechnology, depends on news from these different sectors. Progress in clinical trials for its pharmaceutical assets is a key driver of high volatility.
Weekly dynamics of market capitalization of the market segment - Investors holding
Rafael Holdings' shares, as a diversified holding, reflect general trends across several sectors. Its performance is interesting to compare with the biotech industry average to understand how other assets are helping or hindering the company.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Rafael Holdings' shares, as a diversified holding, reflect general trends across several sectors. Its performance is interesting to compare with the biotech industry average to understand how other assets are helping or hindering the company.
Market capitalization of the company, segment and market as a whole
RFL - Market capitalization of the company Rafael Holdings Inc.
The Rafael Holdings market capitalization chart is a financial valuation of a holding company whose value is primarily determined by its biotechnology investments. It reflects both the successes and failures of its portfolio companies and the value of its real estate. Its dynamics are a complex story, requiring investors to analyze several disparate assets.
RFL - Share of the company's market capitalization Rafael Holdings Inc. within the market segment - Investors holding
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Its sector share reflects the value of its diverse assets and its complex history. The chart below shows how the market values โโthis diversified and evolving holding.
Market capitalization of the market segment - Investors holding
Rafael Holdings is a holding company with interests in real estate and biotechnology. The chart below shows the total market capitalization of all holdings. Its dynamics reflect the market's assessment of management's ability to manage its diverse assets. Rafael is going through a complex period of transformation.
Market capitalization of all companies included in a broad market index - GURU.Markets
The investment holdings visible on the chart may be focused on biotechnology. Rafael Holdings owns stakes in several pharmaceutical companies. Its market capitalization is essentially a valuation of the portfolio of these risky biotech assets.
Book value capitalization of the company, segment and market as a whole
RFL - Book value capitalization of the company Rafael Holdings Inc.
The Rafael Holdings chart shows its asset portfolio after the restructuring. The book value reflects the value of its real estate and pharmaceutical stakes. This is the material base the holding is using to implement its new investment strategy.
RFL - Share of the company's book capitalization Rafael Holdings Inc. within the market segment - Investors holding
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Its stake in the sector's assets reflects its ownership of an office building in Newark and stakes in biotech companies. This represents a hybrid of physical and financial assets.
Market segment balance sheet capitalization - Investors holding
Rafael Holdings, Inc. is a holding company with interests in real estate and pharmaceuticals. Its capital intensity is high due to its ownership of an office building in Newark. Compared to other holdings, its balance sheet is weighed down by this large physical asset.
Book value of all companies included in the broad market index - GURU.Markets
Rafael Holdings' assets are not a single business, but a holding company with stakes in pharmaceutical companies and a commercial real estate portfolio. The balance sheet reflects the combined value of these diverse assets. The chart illustrates the scale of this company, which combines biotechnology investments and real square footage.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Rafael Holdings Inc.
Rafael Holdings is a holding company with assets in real estate and pharmaceuticals. Its market capitalization is the combined value of these disparate assets. The chart shows how investors value its pharmaceutical developments and the value of its real estate.
Market to book capitalization ratio in a market segment - Investors holding
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Its structure is complex, and its valuation depends on the success of its investments. This chart shows how the market is attempting to value this diversified but risky portfolio of assets.
Market to book capitalization ratio for the market as a whole
Rafael Holdings is a holding company with assets in real estate and pharmaceuticals. Its market value is the sum of the valuations of its various businesses. This chart shows how investors view this diversified portfolio and its potential to create value relative to overall market trends.
Debts of the company, segment and market as a whole
RFL - Company debts Rafael Holdings Inc.
Rafael Holdings is a holding company with assets in real estate and pharmaceuticals. Its debt structure can be complex, reflecting the needs of its various businesses. Borrowed funds can be used both for real estate development and to finance clinical trials in its pharmaceutical assets.
Market segment debts - Investors holding
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Its debt structure is the aggregate of the liabilities of its diversified assets. This chart provides an overview of the holding's overall financial strategy for managing its diverse investments and the level of leverage management considers acceptable.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Rafael Holdings Inc.
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. This chart shows its consolidated debt load. Managing debt in a diversified holding company requires balance, as risks in one industry (such as clinical trial failure) can impact the financial stability of another.
Market segment debt to market segment book capitalization - Investors holding
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. This chart compares its total debt, spread across these diverse assets, to the total market capitalization of the entire sector. It allows one to assess how the company manages the risks of its diversified but unrelated portfolio.
Debt to book value of all companies in the market
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Its diversified portfolio allows for flexible financial management. The chart shows the company's overall debt load. Comparisons with other holdings help assess how aggressively it uses debt capital to develop its diverse assets.
P/E of the company, segment and market as a whole
P/E - Rafael Holdings Inc.
For Rafael Holdings, an investment holding company, this chart reflects the overall performance of its real estate and pharmaceutical investments. The price-to-earnings ratio is an average indicator demonstrating the market's confidence in management's ability to identify and develop promising assets while generating income.
P/E of the market segment - Investors holding
This chart shows the average valuation for diversified holdingsโthe benchmark for Rafael Holdings. These companies often trade at a discount to their total assets. Comparing this metric helps investors understand whether Rafael Holdings' discount is higher or lower than the sector average and how the market values โโits asset portfolio.
P/E of the market as a whole
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Its primary asset was previously a stake in a biotech company, but its strategy may be evolving. This chart reflects overall market sentiment. It helps understand how the market views this complex holding and its ability to effectively manage and allocate capital across various assets.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Rafael Holdings Inc.
Rafael Holdings is a holding company with interests in pharmaceutical companies and real estate. Estimating its future profits requires an analysis of its investment portfolio. This chart represents a summary of analyst estimates, reflecting their views on the prospects of biotech assets and real estate values.
Future (projected) P/E of the market segment - Investors holding
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals, specifically biotech companies. This chart compares its future return expectations with the broader market. It demonstrates how the market views its complex structure and the potential of its pharmaceutical investments, which carry both high risks and significant opportunities.
Future (projected) P/E of the market as a whole
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. This chart shows overall market sentiment. RFL's value depends on success in each of its segments. Progress in drug development or a successful real estate deal can have a greater impact on its valuation than overall market trends.
Profit of the company, segment and market as a whole
Company profit Rafael Holdings Inc.
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. This chart shows the combined performance of its holdings. Performance will depend on both the real estate market and the success or failure of its pharmaceutical investments in clinical trials, creating a diversified yet complex profile.
Profit of companies in the market segment - Investors holding
Rafael Holdings is a holding company that owns stakes in early-stage biotech companies and real estate. The company focuses on breakthrough technologies in oncology. This chart shows the overall returns in the investment holdings sector, which are determined by the success of venture capital investments and asset portfolio management.
Overall market profit
Rafael Holdings is a holding company with assets in real estate and pharmaceuticals. Diversification smooths out cyclicality. Real estate is sensitive to economic conditions, while pharmaceutical assets (if they target serious diseases) are acyclical. This chart helps assess the health of one of their business segments.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Rafael Holdings Inc.
Rafael Holdings is a holding company with interests in real estate and biotechnology. Analyzing its future requires a separate valuation of its assets. This chart represents the sum of analysts' forecasts for its pharmaceutical investments and real estate revenue.
Future (predicted) profit of companies in the market segment - Investors holding
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. This chart reflects the combined forecasts for these two sectors. Rafael Holdings' profitability depends on both the value and yield of its real estate portfolio and the success of its pharmaceutical assets, creating a diversified yet complex structure.
Future (predicted) profit of the market as a whole
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Its value is the sum of the values โโof its assets across various sectors. This graph, showing projected total profits, is an indicator of overall economic health, which impacts both the real estate market and the investment climate for biotech companies.
P/S of the company, segment and market as a whole
P/S - Rafael Holdings Inc.
Rafael Holdings is a holding company with interests in real estate and biotechnology. This chart shows how the market values โโits combined revenue from its diverse assets. The valuation is heavily dependent on news from the biotechnology division, which can overshadow its stable real estate revenue.
P/S market segment - Investors holding
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Previously focused on oncology developments, its business model has changed following a restructuring. This chart compares how the market values โโRafael Holdings' current assets and strategy compared to other holding companies and companies in its sectors.
P/S of the market as a whole
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Valuing such a conglomerate is complex. This total market valuation chart can serve as a starting point for analyzing how the market values โโthe sum of the holding's disparate parts and their ability to generate total revenue.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Rafael Holdings Inc.
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. This chart reflects investors' aggregate valuations of the future returns of its various assets. The valuation is based on both real estate rental income and the potential success of its pharmaceutical investments.
Future (projected) P/S of the market segment - Investors holding
Rafael Holdings is a holding company with interests in real estate and biotechnology. This chart compares the company's future earnings expectations with its sector. It reflects the market's overall valuation of its diverse assets and its belief in management's ability to create value from them.
Future (projected) P/S of the market as a whole
Rafael Holdings is a holding company investing in real estate and pharmaceutical developments. Looking at this chart, which reflects general expectations, it's interesting to observe these companies. Their diverse assets react differently to economic cycles, making Rafael Holdings a unique blend of stablecoins and venture capital investments.
Sales of the company, segment and market as a whole
Company sales Rafael Holdings Inc.
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Its revenue, shown in this chart, can be complex and includes rental income from commercial real estate as well as income from its stakes in development-stage pharmaceutical companies.
Sales of companies in the market segment - Investors holding
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Its value is the sum of its various assets. This chart shows how diversified holdings participate in various economic sectors, seeking to create value through portfolio management.
Overall market sales
Rafael Holdings, Inc. is a holding company investing in real estate and pharmaceutical developments. Its value is the combined valuation of these assets. The growth in total economic revenue, reflected in this chart, positively impacts the real estate market and creates a favorable environment for raising capital for the biotech startups in which Rafael invests.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Rafael Holdings Inc.
Rafael Holdings, Inc. is a holding company with interests in real estate and pharmaceuticals. Its future is largely tied to the success of its investments in biotech companies developing cancer treatments. This chart reflects analysts' combined expectations for these two distinct sectors.
Future (projected) sales of companies in the market segment - Investors holding
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Its strategy is to develop and monetize these assets. This chart shows forecasts for the holdings sector, reflecting the overall economic environment in which the company manages its diversified portfolio.
Future (projected) sales of the market as a whole
Rafael Holdings, a diversified holding company, sees this chart as an overall barometer for its assets. The overall economic situation reflected here influences the operating results of each segment, from real estate to pharmaceuticals, and determines the holding's capital allocation strategy.
Marginality of the company, segment and market as a whole
Company marginality Rafael Holdings Inc.
Rafael Holdings is a holding company with assets in real estate and biotechnology. Its financial results represent a blend of very different business models. This chart shows the overall profitability of the entire holding, reflecting management's ability to manage this diversified and unrelated portfolio of assets.
Market segment marginality - Investors holding
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals, particularly oncology. The effectiveness of such a diversified structure depends on management's ability to manage diverse assets and allocate capital. The chart shows how successful this strategy is compared to more focused companies.
Market marginality as a whole
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. This chart shows average profitability, and Rafael is a combination of two very different assets. Their combined value and profitability depend on both the real estate market and the success of their pharmaceutical developments.
Employees in the company, segment and market as a whole
Number of employees in the company Rafael Holdings Inc.
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. This chart shows its corporate team. The size of its staff reflects its activities in managing its assets and identifying new investment opportunities in its key sectors.
Share of the company's employees Rafael Holdings Inc. within the market segment - Investors holding
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. This chart shows the combined workforce size of its various assets. It allows one to assess the proportion of workers Rafael employs across various economic sectors through its subsidiaries, demonstrating the diversification of its investment portfolio.
Number of employees in the market segment - Investors holding
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. This chart shows the total headcount of its various assets. The dynamics of headcount reflect not so much operational activity as the holding's strategy for managing and monetizing its investments in these two sectors.
Number of employees in the market as a whole
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. For such a diversified structure, this chart serves as a general indicator. Employment growth positively impacts the real estate market, while pharmaceutical assets operate according to their own laws of clinical trials.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Rafael Holdings Inc. (RFL)
Rafael Holdings is a holding company with assets in real estate and pharmaceuticals. This ratio would be high for it, reflecting the value of these capital-intensive assets managed by a small corporate team. The chart illustrates the essence of the holding structure.
Market capitalization per employee (in thousands of dollars) in the market segment - Investors holding
Rafael Holdings, Inc. is a holding company with interests in real estate and pharmaceuticals. For such a diversified holding, this metric is an average and reflects the overall efficiency of asset management across various sectors. The chart allows one to assess whether this structure creates additional value per employee.
Market capitalization per employee (in thousands of dollars) for the overall market
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. Following the sale of its majority stake in biotech, its structure has changed. This chart reflects how the market values โโits remaining assets and the strategy of the small management team to monetize or develop them.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Rafael Holdings Inc. (RFL)
Rafael Holdings is a holding company whose primary assets were investments in biotechnology (specifically, Rafael Pharmaceuticals). This chart reflects investment activity, not operating activity. It shows how effectively the small management team manages the holding's capital and assets.
Profit per employee (in thousands of dollars) in the market segment - Investors holding
Rafael Holdings (RFL) is a holding company with real estate assets and (historically) a large stake in biopharmaceutical companies. This chart shows the efficiency of the holding company's corporate core. It reflects how effectively the small management team generates revenue from its assets per employee.
Profit per employee (in thousands of dollars) for the market as a whole
Rafael Holdings is a holding company whose primary asset was investments in biotechnology (Rafael Pharmaceuticals). This chart for the holding company shows the efficiency of asset management. Profit or loss per employee here is essentially the change in the value of their investments (specifically, in biotech) divided by the minimum corporate headcount.
Sales to employees of the company, segment and market as a whole
Sales per company employee Rafael Holdings Inc. (RFL)
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals. This chart shows the average performance of all its assets. The dynamics reflect management's ability to effectively manage this diverse portfolio and generate aggregate income from rental income and potential success in biotechnology.
Sales per employee in the market segment - Investors holding
Rafael Holdings is a holding company whose primary assets were previously a stake in a biotech company and real estate. This chart shows the average revenue per employee in the sector. For a holding company, especially after restructuring, this is a complex metric, but it provides a general idea of โโthe effectiveness of managing its remaining assets.
Sales per employee for the market as a whole
Rafael Holdings, Inc. (RFL) is a holding company that was previously focused on oncology, but after R&D setbacks, it refocused on managing its assets (including real estate) and seeking new investments. This chart shows revenue (primarily from rent) for a small corporate staff.
Short shares by company, segment and market as a whole
Shares shorted by company Rafael Holdings Inc. (RFL)
Rafael Holdings is a holding company that invests in biotech and real estate. Its main biotech asset suffered a major setback in a clinical trial. This chart shows the number of investors betting that the remaining assets (including real estate) are not worth the current valuation, leaving the company without its main growth driver.
Shares shorted by market segment - Investors holding
Rafael Holdings is a holding company with assets in real estate and biotechnology. This chart reflects the bearish sentiment in the sector. It shows how skeptical investors are overall about complex holding structures, anticipating problems in their portfolios or ineffective management across the entire group.
Shares shorted by the overall market
Rafael Holdings is a holding company whose core value is concentrated in biotech and real estate investments. This chart measures overall market pessimism. When fear dominates, investors view holdings negatively because they are more difficult to value. They see risks in both RFL biotech assets (speculative sector) and real estate (cyclical sector), leading to sell-offs.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Rafael Holdings Inc. (RFL)
Rafael Holdings, Inc. is a holding company that has shifted its focus from biotech to real estate and other asset investments. This shift in strategy is causing volatility. This oscillator helps track when investors are overbuying (above 70) shares on news of new deals or overselling (below 30) during periods of uncertainty.
RSI 14 Market Segment - Investors holding
Rafael Holdings (RFL) is an investment holding company (the "remnants" of biotech and real estate). The "Investors Holdings" sector is a mixed bag. RSI\_14\_Seg shows the overall sentiment. It helps us understand: is RFL's growth due to its assets or the general "hype"?
RSI 14 for the overall market
Rafael Holdings (RFL) is a diversified holding company. This chart reflects the value of its assets (often public stocks or risky projects). During periods of market euphoria, the value of its portfolio rises. During periods of market panic, the value of these assets falls, which directly impacts the holding company's valuation.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast RFL (Rafael Holdings Inc.)
Rafael Holdings is a holding company whose primary assets include real estate in New Jersey and a stake in a biotech company (LipoMedix). This chart shows the average 12-month forecast of analysts. Their target price is essentially a "sum of the parts" estimate of these disparate assets.
The difference between the consensus estimate and the actual stock price RFL (Rafael Holdings Inc.)
Rafael Holdings is a holding company that invests in real estate and biotechnology. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their "combined" valuation of these diversified and unrelated assets.
Analyst consensus forecast for stock prices by market segment - Investors holding
Rafael Holdings is a diversified holding company with two distinct assets: stable (real estate) and speculative (stakes in biotech startups). This chart shows analysts' overall expectations for the entire investment holding sector. It reflects whether experts believe in synergies between these diverse assets or anticipate a decline.
Analysts' consensus forecast for the overall market share price
Rafael Holdings is a holding company that has undergone a transformation. Previously focused on biotech (cancer treatment), it now owns real estate assets and stakes in other companies. This chart shows overall market sentiment. For Rafael, a company with a complex structure, overall optimism is important, as it supports the value of its diversified assets.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Rafael Holdings Inc.
Rafael Holdings is a holding company that has undergone a radical transformation. Following the failure of their flagship oncology R&D business, they essentially became a shell company managing their remaining assets, including real estate. This chart is a summary indicator of their residual value. It reflects the market's valuation of their cash, real estate, and any remaining investments.
AKIMA Market Segment Index - Investors holding
Rafael Holdings (RFL) is a holding company with interests in real estate and, historically, biotechnology (through investments in companies focused on cancer metabolism). The chart shows the average index for the segment, helping investors assess how well this holding manages its diversified assets compared to the sector average.
The AKIM Index for the overall market
Rafael Holdings is a holding company with interests in real estate and pharmaceuticals (through stakes in Rafael Pharma and LipoMedix). This chart, which reflects the market average, provides a macro backdrop. It helps assess how RFL, which manages diverse assets and real estate, compares to the overall macroeconomic environment.